Loading stock data…
$26.37-0.50 (-1.86%)
Electromed, Inc.
Electromed, Inc. in the Healthcare sector is trading at $26.37 with a market capitalization of $220M. Wall Street consensus targets $48.50 (2 analysts), implying a +83.9% move over the next 12 months. The stock is currently near its 52-week low of $23.01, remaining 15.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 25 is oversold, raising the odds of a near-term bounce. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $19.42M↑ | $18.57M↓ | $18.90M↑ | $16.89M↓ | $17.39M |
| Gross Profit | $15.28M↑ | $14.64M↓ | $14.82M↑ | $13.20M↓ | $13.62M |
| Operating Income | $3.83M↑ | $3.77M↑ | $3.62M↑ | $2.67M↓ | $3.04M |
| Net Income | $3.40M↑ | $3.00M↑ | $2.76M↑ | $2.14M↓ | $2.20M |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The co...